Pharming Group (PHAR)
9.43
+0.43
(+4.78%)
USD |
NASDAQ |
May 21, 16:00
9.50
+0.07
(+0.74%)
After-Hours: 20:00
Pharming Group Market Cap: 635.05M for May 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 21, 2024 | 635.05M |
| May 20, 2024 | 606.09M |
| May 17, 2024 | 626.30M |
| May 16, 2024 | 643.13M |
| May 15, 2024 | 645.49M |
| May 14, 2024 | 648.52M |
| May 13, 2024 | 628.99M |
| May 10, 2024 | 673.44M |
| May 09, 2024 | 652.44M |
| May 08, 2024 | 639.77M |
| May 07, 2024 | 650.54M |
| May 06, 2024 | 654.92M |
| May 03, 2024 | 673.44M |
| May 02, 2024 | 673.43M |
| May 01, 2024 | 703.74M |
| April 30, 2024 | 657.95M |
| April 29, 2024 | 667.38M |
| April 26, 2024 | 659.99M |
| April 25, 2024 | 703.74M |
| April 24, 2024 | 661.99M |
| April 23, 2024 | 646.50M |
| April 22, 2024 | 668.05M |
| April 19, 2024 | 673.44M |
| April 18, 2024 | 628.32M |
| April 17, 2024 | 684.89M |
| Date | Value |
|---|---|
| April 16, 2024 | 684.89M |
| April 15, 2024 | 725.97M |
| April 12, 2024 | 709.13M |
| April 11, 2024 | 760.98M |
| April 10, 2024 | 705.76M |
| April 09, 2024 | 673.44M |
| April 08, 2024 | 717.21M |
| April 05, 2024 | 713.84M |
| April 04, 2024 | 719.91M |
| April 03, 2024 | 738.09M |
| April 02, 2024 | 724.62M |
| April 01, 2024 | 760.00M |
| March 28, 2024 | 727.44M |
| March 27, 2024 | 727.44M |
| March 26, 2024 | 728.11M |
| March 25, 2024 | 756.30M |
| March 22, 2024 | 756.30M |
| March 21, 2024 | 738.18M |
| March 20, 2024 | 738.18M |
| March 19, 2024 | 738.18M |
| March 18, 2024 | 771.73M |
| March 15, 2024 | 770.98M |
| March 14, 2024 | 732.81M |
| March 13, 2024 | 745.56M |
| March 12, 2024 | 797.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
428.50M
Minimum
Jun 16 2022
1.066B
Maximum
Dec 23 2020
721.39M
Average
743.75M
Median
Nov 01 2022
Market Cap Benchmarks
| uniQure NV | 233.04M |
| ProQR Therapeutics NV | 155.16M |
| Merus NV | 2.566B |
| argenx SE | 21.20B |
| Pharvaris NV | 1.108B |
Market Cap Related Metrics
| PS Ratio | 2.659 |
| PEG Ratio | -0.3536 |
| Price to Book Value | 3.084 |
| Price | 9.43 |
| Earnings Yield | -1.70% |
| PEGY Ratio | -0.3536 |